The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy
Gerhard Hamilton, Adelina Plangger Department of Vascular Surgery, Medical University of Vienna, Vienna, AustriaCorrespondence: Gerhard HamiltonDepartment of Vascular Surgery, Medical University of Vienna, Spitalgasse 23, Vienna, A-1090, AustriaTel +43-1-40400Email gerhard.hamilton@meduniwien.ac.atA...
Guardado en:
Autores principales: | Hamilton G, Plangger A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bbfd59578553413294407459f3416055 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study
por: Kiwan Kim, et al.
Publicado: (2021) -
CELLULAR IMMUNOTHERAPY: A MODERN APPROACH TO TREATMENT OF ONCOLOGICAL DISEASES
por: Yu. N. Lezhnin, et al.
Publicado: (2018) -
Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells
por: Alireza Rajabzadeh, et al.
Publicado: (2021) -
Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences
por: Tor Henrik Anderson Tvedt, et al.
Publicado: (2021) -
How Can We Engineer CAR T Cells to Overcome Resistance?
por: Glover M, et al.
Publicado: (2021)